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S U M M A R Y
Background: Studies on candidemia occurring among adults in Southern African are limited. We aimed to
document the epidemiology of candidemia among adults in Soweto.
Methods: This was a retrospective hospital-based study in three discrete periods, involving 9 years, from
1990 to 2007.
Results: Two hundred and sixty-six patients were identiﬁed. Case rates were 2.8 cases/10 000
admissions in 1998–2002 and 3.6 episodes/10 000 hospitalizations in 2005–2007. In 1990, Candida
albicans caused 62% and Candida tropicalis caused 23% of episodes. In 2005–2007, major species were C.
albicans (46%), Candida parapsilosis (25%), and Candida glabrata (23%), with little change compared to
1998–2002. Major predisposing conditions were abdominal surgery (43%), HIV infection (19% in 2005–
2007), trauma (16%), diabetes mellitus (12%), and cancer (8%). General wards superseded intensive care
as the major diagnostic setting in 2005–2007. The crude mortality was 60%. Among 22 HIV-infected
patients with a median CD4 cell count of 68/ml, three were of community-onset. C. albicans caused 73% of
cases. Five patients had another predisposing condition and ﬁve had central venous catheters. The
mortality was 73%.
Conclusions: Soweto has a pattern of Candida species different from other continents. HIV infection and
trauma were important predisposing conditions.
 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Candidemia is an important cause of hospital-associated
infection.1 The crude mortality ranges from 20% to 61%. Non-
albicans Candida species are increasingly frequent, although the
rates of speciﬁc species vary geographically, even within coun-
tries.1,2 Major predisposing conditions for candidemia include
neutropenia, abdominal surgery, diabetes mellitus, cancer, and
renal failure.1
Little has been published on candidemia among adults in
Southern Africa. An international study from 1992 to 2001 used
331 South African isolates, subsumed in the Paciﬁc-Asia group,
with 81% Candida albicans, 10% Candida glabrata, 4% Candida
parapsilosis, 3% Candida krusei, and 1% Candida tropicalis.2 In
Bloemfontein, South Africa, a 1-year study in 1989 yielded 106
specimens, with C. albicans comprising 42%, C. tropicalis 26%, C.
parapsilosis 20%, and C. glabrata 7%.3 Both studies included children
and adults. In a review of worldwide publications from 1996 to
2009 detailing candidemia isolates, Africa was conspicuous by its
absence.4* Corresponding author. Tel.: +27 82 978 0585; fax: +27 11 938 1454.
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patients, does not progress to candidemia. Candidemia occurred in
1% of patients in each of two HIV-infected cohorts.5,6 The rate of
HIV infection among all subjects with candidemia has been 2–10%
in the USA,7,8 0.6% in Australia,9 3% in Brazil,10 and 8% in Spain.11
We collected data on candidemia in adults over 9 years in three
discrete periods from 1990 to 2007. The aim of this study was to
document the epidemiology of Candida species, to detail major risk
factors and outcome, and to describe candidemia in HIV-infected
patients.
2. Methods
2.1. Study site
Chris Hani Baragwanath Hospital, a 2700-bed public sector
hospital, is the main hospital serving Soweto. It provides
comprehensive services, but does not have a transplant service.
It is the tertiary referral hospital for the region. It admitted
100 000–110 000 patients per year, predominantly adults, in
1998–2002 and 2005–2007. The intensive care unit (ICU), which
caters for adults, children, and neonates, admitted 3726 adults
between 2005 and 2007. In the ICU, parenteral nutrition is
frequently used, as are broad-spectrum antibiotics and central
lines, and most patients are ventilated. Fluconazole is freely used inses. Published by Elsevier Ltd. All rights reserved.
Table 1
Distribution of Candida species in adults with candidemia over three periods, 1990–
2007
Candida species Period
1990
(n = 13), n (%)
1998–2002
(n = 138), n (%)
2005–2007
(n = 117), n (%)
C. albicans 8 (62) 61 (44) 54 (46)
C. parapsilosis 0 (0) 38 (28) 29 (25)
C. glabrata 1 (8) 30 (22) 27 (23)
C. krusei 0 (0) 5 (4) 4 (3)
C. tropicalis 3 (23) 3 (2) 3 (3)
C. guilliermondii 0 (0) 1 (1) 0 (0)
C. lusitaniae 1 (8) 0 (0) 0 (0)
Table 2
Demographic characteristics, predisposing factors, and outcome in adults with
candidemia and with clinical records over three periods, 1990–2007
Period 1990
(n = 13)
1998–2002
(n = 138)
2005–2007
(n = 117)
Patients with records, n 13 81 109
Demographics
Age, years, median (range) 31 (15–55) 39 (14–80) 43 (14–89)
Male, n (%) 6 (46%) 45 (56%) 50 (54%)
Predisposing condition, n (%)
Abdominal surgery 9 (69%) 46 (57%) 33 (30%)
HIV infection 0 9 (11%) 18 (17%)
Diabetes mellitus 1 (8%) 9 (11%) 16 (15%)
Cancer 1 (8%) 4 (5%) 11 (10%)
Gunshot wound 3 (23%) 11 (14%) 5 (5%)
Blunt trauma 2 (15%) 4 (5%) 4 (4%)
Burns 0 1 (1%) 3 (3%)
Sepsis 2 (15%) No data 9 (8%)
Other surgery 2 (15%) 14 (17%) 16 (15%)
Steroids 1 (8%) No data 4 (4%)
Central venous catheter 9 (75%) 62 (77%) 55 (50%)
Antibiotics 10 (83%) 65 (80%) 89 (82%)
Ventilation 5 (42%) 55 (68%) 39 (36%)
Crude mortality, n (%) 7 (54%) 53 (65%) 62 (57%)
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invasive candidiasis and for treating oral–esophageal candidiasis,
but not for prophylaxis. The hospital, as a public sector hospital, is
government run and ﬁnanced. Most patients pay a negligible
amount towards their care. There is little detailed costing data
available. Doctors are encouraged to be economic in their approach
to diagnostic testing, but there is no formal restriction on
performing blood cultures.
2.2. Patient population
A retrospective cohort study was performed of adult (14 years
of age) patients hospitalized and diagnosed with candidemia
during the years 1990, 1998–2002, and 2005–2007. Candidemia
was deﬁned as the presence of Candida species in a peripheral
blood culture. Cases were identiﬁed from a laboratory paper-based
system. Patient clinical and laboratory records were used. The
2005–2007 period was added to the study to compensate for the
many missing clinical records for the 1998–2002 period.
2.3. Microbiology
Blood cultures were processed using a Bactec NR600 system in
1990 and with a BacT/Alert system from 1998 onwards. C. albicans
was identiﬁed by the germ tube test. Other Candida species were
identiﬁed by API 20C Aux (bioMe´rieux) until 2007 and by Candida
Auxacolor 2 (Bio-Rad) in 2007.
2.4. Ethics
This study was approved by the Committee for Research on
Human Subjects of the University of the Witwatersrand, Johannes-
burg, South Africa.
2.5. Statistics
Chi-square test calculations or the Fisher’s exact test were used
for group comparisons.
3. Results
There were 268 Candida species in 266 adults during the study
periods: 13 in 1990, 28 per year in 1998–2002, and 39 per year in
2005–2007. In 1998–2002, there were 2.8 cases/10 000 admissions
and in 2005–2007 there were 3.6 episodes/10 000 hospitalizations.
Patients in the ICU comprised 156 (59%) of the total: eight (62%) in
1990, 99 (72%) in 1998–2002, and 49 (42%) in 2005–2007
(p < 0.0001). In the ICU, there were 132 episodes/10 000 admis-
sions in 2005–2007. Case records were available for 13 (100%)
cases in 1990, 81 (59%) in 1998–2002, and 109 (95%) in 2005–2007.
The species frequencies are detailed in Table 1. C. albicans was
the most common species in all periods. It was followed byC. tropicalis in 1990, and by C. parapsilosis and C. glabrata, each
comprising >20% of isolates, in the two later periods. C. albicans
accounted for ﬁve (63%) ICU episodes in 1990, for 41 (41%) in
1998–2002, and for 14 (29%) in 2005–2007 (p = 0.13). On the
general wards, C. albicans was found in three episodes (60%) in
1990, 20 (51%) in 1998–2002, and 40 (59%) in 2005–2007.
The median time to candidemia for patients studied in 1990 and
2005–2007 was 14 days (range 0–128 days) and the median length
of admission (including time to death of patients who died) was 21
days (range 1–559 days). In 2005–2007, six patients had
candidemia that was culture-positive at the time of hospitalization
or within 48 h of admission, ﬁve with C. albicans and one with C.
glabrata. There was insufﬁcient information in their records to be
able to conclude that it was truly community-acquired candidemia
rather than hospital-acquired, related to a recent admission. Two
had diabetes mellitus and three had AIDS and were on anti-
tuberculosis treatment; the other three had an unknown HIV
status. All six died.
The major predisposing clinical conditions overall, other than
HIV infection, were abdominal surgery (43%), trauma (16%),
diabetes mellitus (12%), and cancer (8%) (Table 2). The second
most common in 2005–2007 was HIV infection (19% of the cohort
and 17% of those with case records). Trauma, comprising gunshot
wounds, stab wounds, blunt trauma, and burns, was encountered
in 38% of patients in 1990, 21% in 1998–2002, and 11% in 2005–
2007.
In 2005–2007, HIV infection was documented in 22 patients
(19% of the cohort and 42% of the 45 who were tested) of whom 18
had case records. Their median age was 37 years (range 16–69
years) and 15 (68%) were male. Ten had CD4 cell counts, median
68/ml (range 2–216/ml). Two patients were on antiretroviral
therapy (ART). Sixteen (73%) died. C. albicans was found in 16 (73%),
C. parapsilosis and C. glabrata in two each, and C. tropicalis and C.
krusei in one each. All patients were on the adult medical wards
and none were admitted to the ICU, although one was ventilated.
Five patients had another predisposing condition: three had
malignancy (two non-Hodgkin’s lymphoma and one lung carcino-
ma), and one each had diabetes mellitus and end-stage renal
disease. None had abdominal or other surgery. The other patients
with records had tuberculosis (n = 5), gastroenteritis (n = 5), and
one each pneumonia, chronic hepatitis B, and stroke. Five had a
central venous catheter. In 1998–2002, HIV infection was
documented in nine patients (7% of the cohort and 27% of 33
tested).
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records (Table 2). For C. albicans, 63 (69%) of 91 patients died, for C.
parapsilosis, 23 (46%) of 50 died, and for C. glabrata, 27 (57%) of 47
died (p = 0.02).
4. Discussion
In this single-center cohort in Soweto, the species distribution
was stable between the periods 1998–2002 and 2005–2007. The
pattern differed from that on other continents with C. albicans, as
expected, the most common species, but followed by C. parapsilosis
and C. glabrata comprising >20% each. C. glabrata is found at similar
rates in North America and Europe, while C. parapsilosis is common
in Southern Europe, Australia, and South America, but less so in the
USA. The low rate of C. tropicalis was similar to that in Europe, but
lower than Brazil and North America, and C. krusei was low in
almost all regions.4,8–10 There was a shift from the 1990 pattern
when C. tropicalis was the second most common. The stability of
the overall pattern between the periods 1998–2002 and 2005–
2007 masked the decline in C. albicans in the ICU, while it was
dominant on the general wards and in HIV-infected patients.
The increasing proportion on the general wards in Soweto was
similar to that in Queensland, Australia where the general ward
setting increased from 44% to 60% of cases over 10 years.12
Clinicians need to be aware of this in both nosocomial and
community-onset sepsis. ICU rates nevertheless remain much
higher than those on general wards. The rate of candidemia of 2.6–
3.8/10 000 admissions was similar to that in many other countries,
but much lower than that in Brazil where it was 24.9 cases/
10 000.8,10,13
Although the proportion of patients tested for HIV was low,
<50% of those tested were HIV-seropositive. Only ﬁve patients had
other recognized predisposing conditions. The HIV-infected
patients from Soweto were generally similar to those from Rome,
Italy, and Bobigny, France.5,6 Patients generally had advanced
immunosuppression. The number of patients on ART differed, with
9% in Soweto contrasting with 35% in Rome and 77% in Bobigny.
The use of central venous catheters was the only independent risk
factor for candidemia in Rome.5 Central venous catheter use was
lower in Soweto. The fact that none of the HIV-infected patients in
Soweto was in the ICU and only one was ventilated, and that few
had other predisposing conditions or central venous catheters,
would suggest that it is a speciﬁc group requiring further study.
The major predisposing clinical conditions in Soweto, other
than HIV infection, were abdominal surgery, trauma, and diabetes
mellitus. Abdominal surgery was also important in Bloemfontein
(30%),3 USA (14%),7 and Brazil (25%).10 In Soweto, cancer at 8% was
much less common than in the USA (26%),7,8 Brazil (27%),10 Spain
(42%),11 and Australia (45%).9 Burns and trauma accounted for 5.5%
of hospital-acquired candidemia in Australia.9
Limitations of this study include the retrospective nature of the
study and missing clinical records in 1998–2002. Testing for HIV
infection was not routine. The rate of candidemia for 1990 couldnot be calculated due to inaccurate hospitalization data for the
year. No routine susceptibility testing was performed over the
period of the study. Cases of candidemia were likely to have been
missed due to the fact that blood cultures are not invariably
performed in patients with suspected nosocomial sepsis, at least
partly due to economic considerations by some clinicians.
In conclusion, this study from Soweto highlights a pattern of
non-albicans Candida species different from other continents, the
importance of general wards as settings for candidemia in adults,
and HIV infection and trauma as important predisposing
conditions.
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